Back
Halozyme Therapeutics Stock Predictions
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
72
HALO
Halozyme Therapeutics
Last Price:
58.12
Seasonality Move:
16.49%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Halozyme Therapeutics Stock Forecast
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 32.7% based on the past 20 years of stock performance.
- Halozyme Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Halozyme Therapeutics Stock Undervalued?
The current Halozyme Therapeutics [HALO] share price is $58.46. The Score for HALO is 72, which is 44% above its historic median score of 50, and infers lower risk than normal. - HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 32.7% based on the past 20 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
72
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
- Halozyme Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
65.53
52-Week Low:
33.15
Prediction Charts
Market Cap:
7.44B
Price in USD:
58.46
Volume:
1.89M
Beta:
1.48
Technical Analysis
SMA50:
57.09
SMA100:
55.63
SMA200:
47.88
52-Wk Change:
64.31%
Stock Predictions
-
Is Halozyme Therapeutics stock public?
Yes, Halozyme Therapeutics is a publicly traded company. -
What is the Halozyme Therapeutics stock quote today?
The Halozyme Therapeutics stock price is 58.46 USD today. -
How to buy Halozyme Therapeutics stock online?
You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-15 | 53.84 | 53.82 | 54.66 | 53.24 |
| Oct-16 | 53.43 | 53.46 | 53.70 | 52.83 |
| Oct-18 | 52.20 | 52.61 | 53.09 | 52.20 |
| Oct-21 | 52.60 | 51.77 | 52.77 | 51.45 |
| Oct-22 | 51.68 | 51.55 | 52.03 | 51.14 |
| Oct-23 | 51.46 | 50.80 | 51.70 | 50.51 |
| Oct-24 | 50.79 | 49.30 | 50.79 | 49.12 |
| Oct-25 | 49.35 | 49.25 | 49.84 | 48.84 |
| Oct-28 | 49.72 | 50.46 | 50.78 | 49.71 |
| Oct-29 | 50.17 | 50.64 | 50.96 | 50.10 |
| Oct-30 | 50.46 | 50.59 | 51.08 | 50.03 |
| Oct-31 | 50.56 | 50.59 | 51.21 | 50.01 |
| Nov-1 | 55.66 | 57.15 | 57.62 | 52.56 |
| Nov-4 | 56.82 | 58.46 | 59.39 | 56.82 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.